Atopic dermatitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 18-65 years, regardless of gender. 2. Patients with atopic dermatitis who were diagnosed according to the diagnostic criteria of Hanifin&Rajka atopic dermatitis. 3. The diameter of target lesions is 2-10cm, located in the extremities or trunk. 4. The area of skin lesions before treatment is less than 10% of body surface area. 5. The total score of symptoms and signs is more than 5 points. 6. Be able to adhere to the requirements of external use of Furou moisturizer and glucocorticoid, and regular follow-up. 7. Have read the instructions of the subject, agree and sign the written informed consent.
Exclusion criteria
Exclusion criteria: 1. Allergic to experimental drugs. 2. The rash is locally associated with viral, bacterial or fungal infection; 3. Serious liver and kidney diseases, blood diseases, autoimmune diseases, chronic severe infections, diabetes, mental illness, etc.; 4. Malignant tumors or other serious diseases that may interfere with the proper evaluation of efficacy; 5. Topical corticosteroid withdrawal time was less than 1 week; 6. The withdrawal time of systemic corticosteroids and other immunosuppressants (Tripterygium, etc.) is less than 4 weeks. 7. Pregnant and nursing women. 8. Skin lesions on the face and skin folds. 9. Other reasons the researchers considered unsuitable for inclusion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Eczema area and severity index; | — |
Countries
China
Contacts
Beijing Friendship Hospital affiliated to Capital Medical University